Skip to main content
uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
15.63
-1.49 (-8.70%)
At close: Feb 27, 2026, 4:00 PM EST
15.80
+0.17 (1.09%)
After-hours: Feb 27, 2026, 7:59 PM EST

uniQure Revenue

uniQure had revenue of $3.70M in the quarter ending September 30, 2025, with 61.83% growth. This brings the company's revenue in the last twelve months to $15.75M, down -44.90% year-over-year. In the year 2024, uniQure had annual revenue of $27.12M with 71.17% growth.

Revenue (ttm)
$15.75M
Revenue Growth
-44.90%
P/S Ratio
61.81
Revenue / Employee
$75,364
Employees
209
Market Cap
973.62M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202427.12M11.28M71.17%
Dec 31, 202315.84M-90.64M-85.12%
Dec 31, 2022106.48M-417.52M-79.68%
Dec 31, 2021524.00M486.49M1,296.82%
Dec 31, 202037.51M30.23M415.23%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pharming Group 362.27M
Xeris Biopharma Holdings 266.14M
Geron 183.88M
Phathom Pharmaceuticals 175.11M
Day One Biopharmaceuticals 158.18M
AbCellera Biologics 75.13M
Aktis Oncology 5.56M
Inhibrx Biosciences 1.40M
Revenue Rankings

QURE News

More News